![]() |
市場調查報告書
商品編碼
1776216
小寶寶用保溫器具的全球市場:洞察,競爭情形,市場預測:2032年Baby Warming Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 |
預計在2025年至2032年的預測期內,嬰兒保溫設備市場將以5.72%的複合年增長率成長。嬰兒保溫設備的需求受到多種關鍵因素的驅動,包括早產數量的增加、新生兒疾病發生率的上升(包括低體溫、低血糖、呼吸窘迫、代謝性酸中毒及其相關併發症),以及感染風險的增加。此外,先天性畸形盛行率的上升以及新興市場主要公司持續的產品開發和上市活動,也進一步推動了該市場的成長。綜合起來,這些因素為市場持續擴張創造了有利環境,預計嬰兒保溫設備市場將在2025年至2032年期間實現強勁穩定的成長。
嬰兒保溫器市場動態:
根據世界衛生組織 (WHO) (2024) 的數據,2022年,超過230萬新生兒在出生後第一個月內死於各種新生兒疾病,包括體溫過低、先天性異常、感染和神經系統疾病。新生兒,尤其是早產兒,極易快速失溫,可能導致危及生命的併發症。許多此類死亡可以透過使用能夠在出生後立即維持適當且穩定體溫的嬰兒保溫器及時提供保溫支持來預防。
新生兒死亡率和相關疾病發病率的上升正在推動嬰兒保溫器市場的成長。根據聯合國兒童基金會 (2023) 的數據,全球每年約有 1,500 萬嬰兒(約佔活產嬰兒總數的十分之一)早產。 BLISS UK (2024) 的數據顯示,每年有超過 1,300 萬例早產,撒哈拉以南非洲和南亞地區的早產率最高。光是在英國,每年就有約 58,000 名嬰兒早產。這一全球趨勢正在產生對先進嬰兒保溫裝置的強勁需求,並推動市場成長。早產兒特別容易發生新生兒體溫過低,可能導致感染、呼吸窘迫甚至死亡等嚴重併發症。嬰兒保溫裝置透過提供持續的熱支持,在穩定這些脆弱新生兒的病情方面發揮關鍵作用。
除了早產之外,肺炎和敗血症等其他新生兒疾病也進一步推動了市場需求。聯合國兒童基金會 (UNICEF)(2024 年)報告稱,全球每 10 萬名兒童中有超過 1400 例肺炎,而美國國立衛生研究院 (US National Institutes of Health)(2023 年)估計,每年新生兒敗血症病例數約為 130 萬例。
此外,根據 Heliyon(2024 年)發表的一項研究,每年約有 110 萬新生兒患上高膽紅素血症(黃疸),這種情況也可能因體溫過低而加劇。在這種情況下,維持穩定的溫度環境對於有效治療、免疫功能和生存至關重要。
然而,與嬰兒保溫裝置相關的限制、嚴格的監管要求和產品召回是可能限制嬰兒保溫裝置市場成長的關鍵限制因素。
嬰兒保溫器市場細分分析:
依產品類型劃分的嬰兒保溫器市場中,輻射保溫器類別預計在2024年佔據最大市場佔有率。此類別的成長主要得益於新生兒疾病發病率的上升以及嬰兒輻射保溫器在新生兒護理中提供的臨床益處。新生兒,尤其是早產兒,極易快速散熱,這會增加他們的低體溫症風險,而低體溫症是一種可能危及生命的疾病。新生兒輻射保溫器提供了一個可控的開放式護理環境,有助於在醫療評估、復甦和治療程序等關鍵時刻維持穩定的體溫。
輻射保溫器的一項顯著臨床益處是其能夠根據嬰兒的皮膚溫度自動調節熱量輸出。這些系統使用內建皮膚溫度探頭提供即時回饋,實現精確的溫度控制,最大限度地降低過熱和欠熱的風險,並確保持續、安全的熱環境。輻射加溫器的另一個主要優點是其開放式設計。由於嬰兒被安置在開放式的病床上,醫護人員可以不間斷地檢查、復甦並執行任何必要的干預措施。
市場上先進且廣泛採用的輻射加溫器包括 GE HealthCare 的 Giraffe Warmer 和 Drager 的 Bebiloo® TN300。這些設備具有旋轉床墊等功能,方便嬰兒接觸,並整合皮膚溫度監測器,可持續調節溫度。這些技術創新旨在減少不必要的刺激並改善護理人員的工作流程,使其在新生兒加護病房 (NICU) 和產房中非常有效。
黃疸等新生兒疾病負擔的日益惡化也推動了對輻射加溫器的需求成長。黃疸新生兒,尤其是早產兒和低出生體重兒,通常需要光療,在此期間維持最佳體溫至關重要。輻射加溫器在整個光療過程中對維持體溫穩定、確保安全並改善治療效果起著關鍵作用。
這些因素預計將推動細分市場的發展,並最終推動全球嬰兒保暖設備市場的發展。
預計到2024年,北美將佔據嬰兒保暖設備市場的最大佔有率,這主要得益於幾個關鍵因素。該地區的主導地位主要歸因於新生兒疾病的高發病率、早產率高以及先天性異常發病率的上升。其他優勢包括該地區完善的醫療保健基礎設施和市場領導企業的強大影響力。這些因素共同使北美成為全球嬰兒保暖設備市場的領導市場。
根據美國疾病管制與預防中心 (CDC, 2023) 的數據,2022 年美國約有十分之一的嬰兒早產,相當於每年約有 38 萬名早產兒。早產兒由於體溫調節系統發育不全,特別容易發生低體溫症。嬰兒保溫設備對於維持穩定的體溫並降低早期治療期間發生嚴重併發症的風險至關重要。
先天性異常盛行率的上升進一步增加了對嬰兒保溫設備的需求。根據 CDC (2024) 的數據,心臟病仍然是美國最常見的先天性異常,影響約 1% 的活產嬰兒,即每年約有 4 萬名嬰兒。此外,大約每2,400名新生兒中就有1名會發生胃造口術等情況,通常需要立即進行手術幹預和長期的新生兒護理,因此需要準確且一致的嬰兒保溫設備來支持復健並預防併發症。
根據美國疾病管制與預防中心 (CDC) 2024 年的數據,總體而言,美國大約每33名新生兒中就有1名患有先天性異常,每年約有12萬例。這些新生兒通常需要早期介入和先進的新生兒支援技術,而嬰兒保溫設備在維持關鍵操作過程中的體溫穩定方面發揮關鍵作用。患有先天性缺陷的新生兒通常由於低出生體重和生理紊亂而容易發生低體溫,因此有效的體溫調節對他們的生存和康復至關重要。
此外,新生兒黃疸也顯著增加了對嬰兒保溫設備的需求。根據美國國立衛生研究院 (2023) 的數據,約 60% 的足月新生兒和 80% 的早產兒在出生後第一週內會出現臨床黃疸。這些新生兒通常需要接受光療,在此期間,嬰兒保溫裝置對於維持體溫穩定、提高治療效果以及確保新生兒的舒適度和安全至關重要,從而推動了市場擴張。
此外,北美擁有強大的醫療基礎設施、廣泛的先進醫療技術,以及 GE 醫療、Drager 和 Natus Medical 等行業領導者的影響力。這些公司透過提供高品質、技術先進的嬰兒保溫解決方案,持續推動新生兒護理領域的創新,進一步促進市場成長。
總體而言,早產、先天性異常和新生兒疾病負擔的不斷加重,加上強大的行業支持和醫療保健能力,正在推動北美對嬰兒保溫裝置的需求,鞏固其在全球市場領先地位。
嬰兒保溫器市場的主要參與者
嬰兒保溫器市場的主要參與者包括通用電氣醫療集團 (GE HealthCare)、荷蘭皇家飛利浦公司 (Koninklijke Philips N.V.)、Dragerwerk AG & Co. KGaA、康德樂 (Cardinal Health)、納特斯醫療公司 (Natus Medical Incorporated)、Atom Medical Corp.、NOVOS Medical Corp. Ltd.、Phoenix Medical Systems、Medical Technology Transfer and Services Asia (MTTS)、DAVID、nice Neotech Medical Systems Pvt. Ltd.、北京聚龍三友科技有限公司 (Beijing Julongsanyou Technology Co. Ltd.)、Advin Health Care、南京愛美斯醫療科技有限公司 (Nanjing AMIS Medical Technology Co. Ltd.)、Heak Medical Ltd.
嬰兒保溫設備市場的最新發展:
嬰兒保暖器市場研究報告重點
嬰兒保暖器市場常見問題
Baby Warming Devices Market by Product Type (Radiant Warmers, Incubators, and, Others), End-User (Hospitals, Pediatric & Maternity Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increase in number of neonatal disorders & preterm birth and increasing product development and launches activities by key players.
The baby warming devices market is estimated to grow at a CAGR of 5.72% during the forecast period from 2025 to 2032. The demand for baby warming devices is being driven by several critical factors, including the rising incidence of neonatal disorders such as hypothermia and related complications like hypoglycemia, respiratory distress, metabolic acidosis, and increased risk of infections, along with the growing number of preterm births. Additionally, the increasing prevalence of congenital anomalies and ongoing product development and launch activities by leading market players are further fueling growth. Collectively, these factors are creating a supportive environment for sustained market expansion, positioning the baby warming devices market for robust and steady growth from 2025 to 2032.
Baby Warming Devices Market Dynamics:
According to the World Health Organization (2024), more than 2.3 million newborns died within the first month of life in 2022 due to a range of neonatal conditions, including hypothermia, congenital anomalies, infections, and neurological disorders. Newborns, particularly preterm infants, are highly vulnerable to rapid heat loss, which can lead to life-threatening complications. Many of these deaths could be prevented with timely thermal support using baby warming devices, which help maintain an adequate and stable body temperature immediately after birth.
The rising incidence of neonatal mortality and associated conditions is a key driver of growth in the baby warming devices market. According to UNICEF (2023), approximately 15 million babies, about 1 in 10 births globally, are born prematurely each year. Data from BLISS UK (2024), reported over 13 million preterm births annually, with the highest prevalence in sub-Saharan Africa and Southern Asia. In the United Kingdom alone, around 58,000 babies are born prematurely each year. This global trend has created a strong and growing demand for advanced baby warming devices, thereby propelling market growth. Preterm infants are particularly susceptible to neonatal hypothermia, a condition that can lead to severe complications such as infections, respiratory distress, and even death. Baby warming devices play a critical role in stabilizing these vulnerable newborns by providing consistent thermal support.
In addition to prematurity, other neonatal conditions such as pneumonia and sepsis are further fueling market demand. UNICEF (2024) reported over 1,400 cases of pneumonia per 100,000 children globally, while the National Institutes of Health (2023) estimated around 1.3 million annual cases of neonatal sepsis.
Moreover, a study published in Heliyon (2024), found that approximately 1.1 million newborns developed hyperbilirubinemia (jaundice) each year, a condition that can also worsen with hypothermia. Maintaining a temperature-stable environment is essential for effective treatment, immune function, and survival in these cases.
However, the limitations associated with baby warming devices and stringent regulatory requirements and product recalls, among others are some of the key constraints that may limit the growth of the baby warming devices market.
Baby Warming Devices Market Segment Analysis:
Baby Warming Devices Market by Product Type (Radiant Warmers, Incubators, and, Others), End-User (Hospitals, Pediatric & Maternity Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the baby warming devices market, the radiant warmers category is estimated to account for the largest market share in 2024. The growth of the category is primarily driven by the rising incidence of neonatal conditions and the clinical advantages that infant radiant warmers offer in neonatal care. Newborns, especially those born prematurely, are highly susceptible to rapid heat loss, increasing the risk of hypothermia, a serious and potentially life-threatening condition. Infant radiant warmers provide a controlled, open-care environment that helps maintain stable body temperature during critical moments such as medical assessments, resuscitation, or treatment procedures.
A major clinical advantage of radiant warmers is their ability to automatically regulate heat output based on the infant's skin temperature. These systems use integrated skin temperature probes to deliver real-time feedback, enabling precise heat adjustments that ensure a consistent and safe thermal environment minimizing the risk of both overheating and underheating. Another key benefit of radiant warmers is their open-access design. Infants are placed on an open bed, allowing unobstructed access for healthcare providers to examine, resuscitate, or perform necessary interventions without interference, which is especially crucial in emergency and intensive care settings.
Several advanced and widely adopted radiant warmers on the market include the Giraffe Warmer by GE HealthCare and the Babyroo(R) TN300 by Drager. These devices are equipped with features like rotating mattresses for convenient infant access and integrated skin temperature monitoring for continuous thermal regulation. Such innovations are designed to reduce unnecessary stimulation and improve caregiver workflow, making them highly effective for use in NICUs and delivery rooms.
The growing burden of neonatal conditions such as jaundice is also contributing to the increasing demand for radiant warmers. Jaundiced infants, particularly those born prematurely or with low birth weight, often require phototherapy, during which maintaining optimal body temperature is essential. Radiant warmers play a critical role in preserving thermal stability throughout the phototherapy process, ensuring safety and improving treatment outcomes.
Thus, the factors mentioned above are likely to boost the market segment and thereby increase the overall market of baby warming devices across the globe.
North America is expected to dominate the overall baby warming devices market:
North America is projected to hold the largest share of the baby warming devices market in 2024, driven by several key factors. This regional dominance is primarily attributed to the high prevalence of neonatal disorders, a significant rate of preterm births, and the growing incidence of congenital anomalies. Additionally, the region benefits from a well-established healthcare infrastructure and the strong presence of leading market players, which further supports product adoption and accessibility. Collectively, these factors are positioning North America as the leading market in the global baby warming devices market.
According to the Centers for Disease Control and Prevention (CDC, 2023), in 2022, approximately 1 in 10 babies, equated to nearly 380,000 preterm births annually were born prematurely in the United States. Preterm infants are especially vulnerable to hypothermia due to their underdeveloped thermoregulatory systems, making infant warming devices critical in maintaining stable body temperatures and reducing the risk of serious complications during early care.
The demand for baby warming devices is further strengthened by the growing prevalence of congenital anomalies. The CDC data (2024), highlighted that heart defects remain the most common birth defects in the United States, affecting about 1% of births, or roughly 40,000 babies each year. In addition, conditions like gastroschisis, occurring in approximately 1 in every 2,400 births, often require immediate surgical intervention and extended neonatal care, necessitating precise and consistent baby warming devices to support recovery and prevent complications.
Overall, congenital anomalies affect approximately 1 in every 33 babies in the U.S., accounting for around 120,000 cases annually, according to CDC (2024). These newborns frequently need early intervention and advanced neonatal support technologies, with baby warming devices playing a vital role in maintaining thermal stability during critical procedures. Infants affected by birth defects are often more susceptible to hypothermia due to low birth weight and physiological impairments, making effective thermal regulation essential for survival and recovery.
Additionally, neonatal jaundice significantly contributes to the demand for baby warming devices. According to the National Institutes of Health (2023), approximately 60% of term and 80% of preterm newborns developed clinical jaundice within the first week of life. These infants often undergo phototherapy, during which baby warming devices are essential to maintain a stable body temperature, enhancing treatment effectiveness and ensuring the infant's comfort and safety, thereby driving the market expansion.
Moreover, North America also benefits from a robust healthcare infrastructure, widespread access to advanced medical technologies, and the presence of key industry players such as GE HealthCare, Drager, and Natus Medical. These companies continue to drive innovation in neonatal care by offering high-quality, technologically advanced infant warming solutions, further contributing to market growth.
Collectively, the rising burden of preterm births, congenital anomalies, and neonatal conditions, combined with strong industry support and healthcare capabilities, is propelling the demand for baby warming devices in North America, reinforcing its position as a leading region in global market.
Baby Warming Devices Market Key Players:
Some of the key market players operating in the baby warming devices market include GE HealthCare, Koninklijke Philips N.V., Dragerwerk AG & Co. KGaA, Cardinal Health, Natus Medical Incorporated, Atom Medical Corp., NOVOS, Maternova Inc., Fanem, Weyer GmbH, VNG Medical Innovation System Pvt Ltd., Phoenix Medical Systems, Medical Technology Transfer and Services Asia (MTTS), DAVID, nice Neotech Medical Systems Pvt. Ltd., Beijing Julongsanyou Technology Co., Ltd., Advin Health Care, Nanjing AMIS Medical Technology Co., Ltd., Healicom Medical Equipment Co., Ltd., Narang Medical Limited, and others.
Recent Developmental Activities in the Baby Warming Devices Market:
Key takeaways from the baby warming devices market report study
Target audience who can benefit from this baby warming devices market report study
Frequently Asked Questions for the Baby Warming Devices Market: